Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilaprisan in Japanese Subjects With Uterine Fibroids and Heavy Menstrual Bleeding
NCT03476928Phase 3Terminated
- Sponsor
- Bayer
- Start
- Mar 2018
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of vilaprisan in Uterine Fibroids (UF), Heavy menstrual bleeding, sponsored by Bayer. Started Mar 2018; status: terminated.
02
Drugs
vilaprisan
03
Conditions
Uterine Fibroids (UF)Heavy menstrual bleeding
Beyond the preview
Go deeper on NCT03476928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03476928.